As the Director of the Mahidol Vivax Research Unit (MVRU), part of the Center of Excellence for Malaria Research, Dr Jetsumon Prachumsri leads a research team of 30 staff including junior scientists, postdoctoral fellows, graduate students and research technologists. With MVRU she has a wide range of international collaborations, including with the Walter & Eliza Hall Institute, Australia; Pennsylvania State University, USA and Osaka University, Japan.
Dr. Jetsumon Prachumsri’s primary research area is the biology and transmission of Plasmodium vivax. This includes studies of the mosquito vectors, establishing in vitro / ex vivo systems and conducting research to support development of new drugs and vaccines.
Dr. Jetsumon Sattabongkot Prachumsri has worked in the malaria field for over 30 years. Before starting with the Faculty in in 2011 she worked with the Department of Entomology of USAMC-AFRIMS (USA Medical Component Armed Forces Research Institute of Medical Science, Bangkok) for 26 years. Among current projects, Dr Jetsumon is Co-Director of the Southeast Asia Malaria Research Center, a multi-country collaborative project funded by the NIH. The project aims to provide essential epidemiological information for developing and evaluating integrated malaria-control strategies in multiple sites with varying epidemiological conditions. Principal Investigator of another current NIH funded project; “Discovery of novel & validation of P. vivax antigens for identification and monitoring of transmission hot-spots”, which focuses on the identification of P. vivax antigens that can be used for serological screening of recent infection as public health tool to monitor areas that have current transmission. Recently Dr. Jetsumon has been notified for an award from CDMRP on ‘A Novel Vector Control Measure to Combat the Spread of Artemisinin Resistance in the Greater Mekong Subregion’ which will start in late 2016. In 2006 Dr Jetsumon Prachumsri along with her co-researcher, gained a US patent for the Human Hepatocyte Cell line HC04, a cell line useful for in vitro culture of Plasmodium falciparum and P. vivax liver stages parasites.
|1996||Biology PhD||Mahidol University, Thailand|
|1986||Microbiology MS||Mahidol University, Thailand|
|1982||General Science BSc||Chulalongkorn University, Thailand|
Dr. Jetsumon Sattabongkot Prachumsri has more than 180 publications under Sattabongkot J and Prachumsri J. The full list can be seen here.
LAP-like process as an immune mechanism downstream of IFN-γ in control of the human malaria Plasmodium vivax liver stage
Boonhok R, Rachaphaew N, Duangmanee A, Chobson P, Pattaradilokrat S, Utaisincharoen P, Sattabongkot J, Ponpuak M.
Proc Natl Acad Sci U S A. Epub 2016 May 16.
Natural human Plasmodium infections in major Anopheles mosquitoes in western Thailand
Sriwichai P, Samung Y, Sumruayphol S, Kiattibutr K, Kumpitak C, Payakkapol A, Kaewkungwal J, Yan G, Cui L, Sattabongkot J.
Parasit Vectors. 2016 Jan 13;9:17.
Evaluation of CDC light traps for mosquito surveillance in a malaria endemic area on the Thai-Myanmar border
Sriwichai P, Karl S, Samung Y, Sumruayphol S, Kiattibutr K, Payakkapol A, Mueller I, Yan G, Cui L , Sattabongkot J
Parasites & Vectors. 2015; 8(1):636
Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in western Thailand
Longley RJ, Reyes-Sandoval A, Montoya-Diaz E, Dunachie S, Kumpitak C, et al.
Clinical and Vaccine Immunology. 2015 Dec 9;23(2):117-24